Skip to main content

Table 1 Quality of life (QoL) of patients with H&N cancer as measured by the EORCT QLQ-C30 and QLQ-H&N35

From: Clinical and psychosocial factors associated with quality of life in patients with head and neck cancer: an analytical cross-sectional study from a lower-middle-income country

QLQ-C30 Component

Mean (SD)

Global QoL

72.23 (18.48)

Functional Scale

 

Physical Functioning

78.42 (20.83)

Role Functioning

81.00 (26.69)

Emotional Functioning

79.63 (20.60)

Cognitive Functioning

88.53 (17.94)

Social Functioning

80.20 (27.50)

Symptom Scales

 

Fatigue

13.93 (19.52)

Nausea

14.33 (16.80)

Pain

61.53 (27.31)

Dyspnea

10.40 (21.43)

Insomnia

30.80 (25.52)

Appetite Loss

34.40 (30.98)

Constipation

5.20 (17.82)

Diarrhea

17.60 (29.54)

Financial Difficulties

33.73 (39.07)

QLQ-H&N 35 Component

Mean (SD)

Symptom Scale

 

Pain

13.93 (19.53)

Swallowing

14.33 (16.80)

Senses

61.53 (27.31)

Speech

32.31 (33.71)

Trouble eating

30.76 (25.46)

Trouble contacting

14.88 (23.01)

Less sexuality

44.77 (37.07)

Teeth

20.80 (34.61)

Opening mouth

46.00 (38.68)

Dry Mouth

40.26 (34.31)

Sticky Saliva

20.53 (35.32)

Cough

24.80 (30.33)

Felt ill

25.86 (29.22)

Pain killers

70.00 (45.90)

Nutritional supplements

71.60 (45.18)

Feeding tube

49.60 (50.09)

Weight loss

55.60 (49.78)

Weight gain

73.20(44.38)